Disease | multiple endocrine neoplasia type 1 |
Comorbidity | C0011849|diabetes mellitus |
Sentences | 8 |
PubMedID- 24080795 | Two trials of low-glucose-containing peritoneal dialysis regimen in patients with diabetes mellitus show that although this strategy improved glycaemic control, it was associated with increased risk of serious adverse events and mortality. |
PubMedID- 19703761 | Background and aims: once-daily (od) basal insulin glargine (gla) can be used as part of a multiple daily injection regimen in patients with type 1 diabetes mellitus. |
PubMedID- 25406730 | Aims: to investigate the efficacy and tolerability of albiglutide, a weekly glucagon-like peptide-1 receptor agonist, when added to metformin and glimepiride in a triple therapy regimen in people with type 2 diabetes mellitus. |
PubMedID- 21777013 | Seated cuff blood pressure-lowering efficacy of an olmesartan medoxomil-based treatment regimen in patients with type 2 diabetes mellitus. |
PubMedID- 26184575 | Background: gestational diabetes mellitus (gdm) affects 5-8% of pregnant women in australia and is linked to adverse maternal and neonatal outcomes. |
PubMedID- 23325381 | The current study investigated spousal undermining of dietary regimen in 129 patients with type 2 diabetes mellitus. |
PubMedID- 23612512 | The lowest prevalence (6.0%) of type 2 diabetes mellitus in women is reported from south india (rural andhra pradesh; 2006) and the highest (14.0%) by the national urban diabetes survey (2001). |
PubMedID- 25143741 | Idegasp provides similar, noninferior glycemic control to a standard basal-bolus regimen in patients with type 1 diabetes mellitus, with additional benefits of significantly lower episodes of hypoglycemia (particularly nocturnal) and fewer daily insulin injections. |
Page: 1